Alex Gruzdev
Chief Commercial Officer
EVP, Business Development · Chief Growth Officer · SVP of Sales · VP of Marketing · Global Commercial & Business Development Leader
- Send a Message
- +1 (213) 444-8849
- Los Angeles, CA
Executive Summary
For over two decades, I've led commercialization, business development, and strategic partnerships across diagnostics, biotech, AI-enabled healthcare, global health systems, and automotive industries. My work focuses on building long-term, high-value alliances that expand access to advanced testing, accelerate adoption of innovative technologies, and unlock new revenue streams for high-growth companies while delivering measurable P&L impact.
I specialize in end-to-end deal cycles: sourcing, structuring, negotiating, and closing partnerships with clinical networks, hospitals, laboratories, CROs, CDMOs, distributors, GPOs and buying groups, and government/non-government health organizations (NGOs). I've architected multimillion-dollar strategic alliances and health systems partnerships, expanding access to national screening programs across 15+ countries worldwide. My experience includes product commercialization, regulatory-compliant launches (ISO, FDA), international distribution, and leading commercial development of AI-enabled diagnostic platforms that integrate machine learning into clinical, operational, and QC workflows to accelerate adoption and improve field accuracy.
My leadership blends analytical rigor, strategic storytelling, and relationship-driven execution. I build trust quickly, navigate complex stakeholder environments, and translate scientific innovation into commercial outcomes through aligned sales, marketing, and partnership strategies.
Industries
Expertise: Diagnostics Commercialization · Biotech Strategic Partnerships · AI-Enabled Healthcare · Global Health Systems · Automotive Commercial Strategy
Core Competencies
- Commercialization Strategy
- Global Business Development
- GTM Strategy & Execution
- Strategic Partnerships
- Diagnostics Commercialization
- Biotech Market Expansion
- AI-Enabled Healthcare
- Clinical Networks & Laboratories
- CRO/CDMO Partnerships
- Distributor & OEM Partnerships
- National Screening Programs
- Cross-Border Negotiation
- Regulatory & Market Access
- Revenue Growth & P&L Impact
- Deal Sourcing, Structuring & Closing
- Global Health Systems
- Commercial Leadership
- Market Intelligence & Competitive Strategy
- Executive Stakeholder Management
Work Experience
-
2022 - Present
Chief Business Development Officer
Vice President, Sales, Commercial & Business Development (2022 - 2025)
Silver Lake Research, Los Angeles, CA
Strategic Partnerships, Business Development & Global Revenue Growth
- Scaled HemoTypeSC from <100K to 2M+ quarterly tests, driving ~20× revenue growth through partnerships with CHAI, Gates Foundation, Ministries of Health, NGOs, clinical networks, and global distributors across Africa, Asia, and LATAM.
- Managed complex, multi-stakeholder BD cycles with government agencies, NGOs, and global health organizations, securing multi-year national screening agreements and expanding access to 15+ countries.
- Navigated centralized procurement and multi-hospital contracting environments, including GPOs, large buying groups, and coordinated purchasing structures across clinical networks.
- Increased qualified partner leads by 75% through distributor co-marketing programs, competitive positioning, and targeted outreach across priority markets.
Commercialization, Go-to-Market Strategy & Regulatory Readiness
- Directed commercialization and GTM strategy for multiple diagnostic programs, collaborating with Bayer, Meridian, CROs, CDMOs/CMOs on assay development, validation, tech transfer, and regulatory compliance (ISO 13485, FDA, IVDR).
- Built cross-functional integration across R&D, Clinical, Regulatory, QA/RA, Manufacturing, and Operations, accelerating launch timelines and strengthening commercial readiness.
- Oversaw innovation scaling by aligning scientific, regulatory, and operational capabilities with commercialization strategy to accelerate adoption in global markets.
- Provided commercial insights and partnership structuring expertise for early-stage collaborations, including Eli Lilly (monoclonal antibody production for Alzheimer's disease).
AI-Driven Diagnostics & Digital Health Solutions
- Led development of AI-enabled diagnostic platforms, including an AI/ML mobile interpretation system with automated QC, error-reduction workflows, and real-time data capture to support national screening programs.
- Drove commercialization of AI/ML diagnostic tools designed for low-resource environments, improving field accuracy and operational efficiency across global health systems.
- Integrated machine learning into clinical, operational, and QC workflows to accelerate adoption and enhance diagnostic reliability.
- Directed multi-institution clinical collaborations supporting AI validation and deployment across hospitals, laboratories, and national programs.
Enterprise Partnerships, Client Relationships & KOL Engagement
- Strengthened enterprise relationships and secured exclusive strategic partnerships with ECOLAB, Disney Cruise Line, Marriott, Intel, and Tesla, expanding commercial adoption across industrial and consumer markets.
- Directed global Sickle Cell Disease (SCD) program expansion across Africa, Asia, and the Caribbean, collaborating with NGOs, Ministries of Health, KOLs, and clinical leaders to build sustainable national screening programs.
- Executed multi-institution clinical collaborations with NIH, BARDA, MCDC, USDA, and leading academic institutions (UCLA Health, UC Davis, Cornell, Purdue, UAB, Brown, Johns Hopkins, St. Jude, Providence Health) supporting hospital-based validation, multi-site studies, and nationwide deployment.
- Governed enterprise-level relationships with global health agencies, shaping long-term agreements and cross-border commercialization pathways.
Commercial Strategy, Channel Expansion & Revenue Generation
- Built a scalable DTC commercial channel, launching Watersafe on Amazon and Walmart, achieving 200+ daily sales within 3 months.
- Expanded commercial adoption across diagnostics, biotech, industrial, and consumer sectors through strategic positioning, channel development, and partnership expansion.
- Directed pricing strategy, forecasting, and commercial performance metrics to drive measurable P&L impact.
- Developed competitive strategy and market intelligence frameworks to support product positioning and international market expansion.
-
Feb 2020 - Mar 2022
Founder & Executive, Business Development & Commercial Strategy
Gruzdev-Analyze, Los Angeles, CA
Global Business Development, Market Entry & Strategic Partnerships
- Built and scaled a consulting practice delivering commercial strategy, market entry, and business development for biotech, diagnostics, automotive, and FMCG clients across the US, EU, Middle East, and Asia.
- Led client acquisition, opportunity identification, deal sourcing, negotiation, and pipeline development, securing and managing 100+ multi-country engagements with repeat enterprise clients.
- Delivered long-term consulting engagements with Honda R&D, Volkswagen Group, and Stellantis, supporting AI/vision system development, product strategy, and cross-regional commercialization initiatives.
Commercial Strategy, GTM Execution & Product Positioning
- Advised C-suite and senior executives on product commercialization, go-to-market strategy, competitive positioning, and channel programs, translating market insights into actionable commercial plans.
- Designed commercialization frameworks for biotech and diagnostics clients, including value proposition development, pricing architecture, business models, and partner enablement.
Cross-Functional Leadership & Multi-Country Execution
- Managed global cross-functional teams across analytics, commercial strategy, and client delivery, executing complex multi-region programs with measurable commercial impact.
- Delivered strategic BD and commercialization projects for enterprise clients, including market activation, partner development, and sales enablement initiatives.
-
Oct 2007 - Jul 2019
Executive Director, Commercial Strategy & Business Development
GiPA, Paris, France
Global Commercial Development, Enterprise Partnerships & Revenue Growth
- Led commercial development across 10+ countries, driving multi-million-dollar revenue growth through enterprise client acquisition, long-cycle relationship management, and strategic account expansion.
- Managed high-value partnerships with OEMs, Tier 1 suppliers, and global enterprise clients, strengthening commercial adoption across Europe, Asia, and LATAM and shaping cross-regional market penetration.
OEM Programs, Market Expansion & Cross-Border Commercial Strategy
- Directed two major international OEM programs: NGK (Thailand), leading regional commercial strategy, distributor engagement, and market development across Southeast Asia during a two-year in-country assignment; and Hyundai/KIA/Mobis (UAE), based in Dubai, driving parts sales growth, channel optimization, and OEM partnership expansion across the Middle East.
- Delivered a commercial initiative with Mercedes-Benz that increased OEM parts sales by 275% in one year, strengthening dealer network performance and accelerating regional market penetration.
AI-Enabled Solutions, Product Innovation & Commercial Impact
- Developed, launched, and scaled an AI-based SaaS platform that increased fleet sales conversion by 40%; the platform was later acquired by a major technology company, validating product-market fit, commercial impact, and exit execution.
- Designed commercialization frameworks and market entry strategies that influenced OEM and Tier 1 commercial decisions across multiple regions.
Cross-Functional Leadership & Large-Scale Program Delivery
- Led cross-regional teams delivering 500+ strategic programs, ensuring insights translated into commercial actions, dealer programs, and revenue-driving initiatives.
- Built alignment across analytics, commercial strategy, and client delivery teams to execute complex multi-country engagements with measurable commercial impact.
-
Jan 2001 - Jul 2007
Early Career in Commercial Strategy, Government Relations & International Partnerships
Russia & Eastern Europe
Commercial Strategy, Client Engagements & Market Insights
- Led commercial strategy and client engagements across FMCG, retail, and technology sectors, advising executives on pricing, customer behavior, and channel optimization, and shaping early business development and market opportunity identification capabilities.
- Built foundational client relationship and stakeholder management experience through multi-sector engagements requiring cross-functional coordination and strategic insight.
Government Relations, Policy Analysis & Industry Coordination
- Developed early government relations expertise as a committee chair within the national antimonopoly authority and as an assistant to a member of parliament, supporting policy analysis, industry coordination, and regulatory insight across multiple sectors.
- Strengthened communication skills, public-sector engagement, and cross-agency collaboration through direct work with legislative and regulatory bodies.
Academic Leadership, Behavioral Insights & Data-Driven Decision Making
- Taught marketing analytics and research at leading universities (Plekhanov University, Higher School of Economics), strengthening expertise in behavioral insights, data-driven decision making, and analytical frameworks used in later commercial strategy roles.
International Sourcing, Supplier Development & Cross-Border Partnerships
- Led international sourcing & supplier partnerships across Taiwan and China, conducting supplier sourcing, technical due diligence, and manufacturing negotiations for gaming hardware and electronics.
- Orchestrated cross-border supplier development programs, improving production quality, cost efficiency, and operational reliability.
Global Expansion, Digital Platforms & Cross-Functional Execution
- Supported global expansion for a gaming technology company, facilitating the first supply of equipment to a Las Vegas casino and coordinating interdisciplinary teams to launch the company's first digital platform.
- Directed early commercialization and product deployment initiatives, building experience in cross-functional execution, partner enablement, and market activation.
Additional Roles
2012 - 2016
Lecturer, Marketing, Strategy & Business Development
Higher School of Economics, Orel State University, Plekhanov Russian University of Economics
- Delivered courses on marketing strategy, commercial leadership, and business development.
- Mentored students on market analysis, competitive strategy, and commercialization frameworks.
2018 - 2020
Board Member
Avtology (Poland)
- Provided strategic guidance on market expansion and commercial partnerships.
- Oversaw product positioning and commercialization strategy in EU markets.
2016 - 2018
Steering Committee Member
GiPA (EU)
- Contributed to industry research, market intelligence, and strategic insights for automotive and industrial sectors.
2013 - 2025
Chair, Automotive Industry Award Committee "Person of the Year"
- Led evaluation and selection process for industry leadership awards.
Education
- PhD, International MarketingOrel State University
- MA, Human Resources ManagementPlekhanov Russian University of Economics
- MA, Social PsychologyNational University of Science and Technology "MISIS"
- BA, International Relations & AffairsNational Research Nuclear University "MEPhI"
Executive Education
- Stanford University: Descriptive Statistics
- UC Davis: Content Marketing
- MIT Sloan: Agentic AI
- TÜV Rheinland: Quality Management Systems (ISO 9000)
Certifications and Credentials
- Quality Management Systems (ISO 9000)
- Advanced Negotiation & Deal Structuring
- Market Intelligence & Competitive Strategy
- Executive Leadership & Commercial Strategy
Awards and Recognition
- Manager of the Year (2010)
- Best Development Strategy (2012)
- Most Valuable Speaker (2019)
Public Speaking
- Presenter at Sickle Cell Congress (Cameroon)
- Presenter at Sickle Cell Scientific Forum (Nigeria)
- Global Automotive Aftermarket Summit (USA)
- Global Biotech Investing Forum (USA)
- Speaker at 100+ international and dealer conferences in the automotive business
- Represents Silver Lake Research in collaborations with BARDA, ASH, MCDC, and BIO
Selected Partners
Countries
Thought Leadership and Publications
Author of three books on psychology, influence, and analytical decision-making: Breaking the Triangle, Mind Manipulation Mastery, and Intellectual Analysis.
- From DNA Chains to Life Chains: The Genetic Frontier of the 21st Century
- The Oscars of Brand Communications: Where Ideas Save Lives, Not Just Sell Products
- From Unique Identity to "Normalcy": Psychological Transitions in Sickle Cell Disease Following Gene Therapy
- Bacterial Contamination in Fuel Systems: Diesel Virus
- Russia's Automotive Market in 2023: Structural Transformation
- PhD Research Summary: Territorial Branding & Geo-Marketing
Patents
- Total Cost of Ownership Online Calculator (RU 2018611587, 2018)